Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Assets: 2016-2024

Historic Return on Assets for Sunshine Biopharma (SBFM) over the last 9 years, with Dec 2024 value amounting to -0.18%.

  • Sunshine Biopharma's Return on Assets fell 5.00% to -0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.19%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of -0.18% for FY2024, which is 2.00% down from last year.
  • Sunshine Biopharma's Return on Assets amounted to -0.18% in FY2024, which was down 11.35% from -0.16% recorded in FY2023.
  • Over the past 5 years, Sunshine Biopharma's Return on Assets peaked at -0.16% during FY2023, and registered a low of -7.66% during FY2021.
  • Moreover, its 3-year median value for Return on Assets was -0.18% (2024), whereas its average is -0.68%.
  • As far as peak fluctuations go, Sunshine Biopharma's Return on Assets slumped by 393bps in 2020, and later soared by 596bps in 2022.
  • Sunshine Biopharma's Return on Assets (Yearly) stood at -4.87% in 2020, then slumped by 279bps to -7.66% in 2021, then soared by 596bps to -1.70% in 2022, then surged by 154bps to -0.16% in 2023, then fell by 2bps to -0.18% in 2024.